Atypical Endometrial Hyperplasia and Well Differentiated Endometrioid Adenocarcinoma of the Uterine Corpus

Surgical Pathology Clinics

Volumn 4, Issue 1, 2011, Pages 149-198

  Mills, Anne M ^a   Longacre, Teri A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atypical endometrial hyperplasia; Endometrial hyperplasia; Endometrioid adenocarcinoma; Well differentiated endometrial adenocarcinoma

Indexed keywords

ATYPICAL ENDOMETRIAL HYPERPLASIA; CANCER INVASION; CANCER STAGING; CELL ULTRASTRUCTURE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; EVIDENCE BASED PRACTICE; FEMALE; HISTOPATHOLOGY; HUMAN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVIEW; SYMPTOM; WELL DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA;

EID: 79951796712     PISSN: 18759181     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.path.2010.12.007     Document Type: Review

References (79)

1. Hacker N. Uterine cancer. Gynecologic oncology 2009, 36. Lippincott Williams and Wilkins, Philadelphia. J.S. Berek, N.F. Hacker (Eds.).
2. Prat J., Gallardo A., Cuatrecasas M., et al. Endometrial carcinoma: pathology and genetics. Pathology 2007, 39:72-87.
3. Kurman R.J., Kaminski P.F., Norris H.J. The behavior of endometrial hyperplasia. A long-term study of "untreated" hyperplasia in 170 patients. Cancer 1985, 56:403-412.
4. Kendall B.S., Ronnett B.M., Isacson C., et al. Reproducibility of the diagnosis of endometrial hyperplasia, atypical hyperplasia, and well-differentiated carcinoma. Am J Surg Pathol 1998, 22:1012-1019.
5. Mutter G.L. Endometrial intraepithelial neoplasia (EIN): will it bring order to chaos? The Endometrial Collaborative Group. Gynecol Oncol 2000, 76:287-290.
6. Mutter G.L., Baak J.P., Crum C.P., et al. Endometrial precancer diagnosis by histopathology, clonal analysis, and computerized morphometry. J Pathol 2000, 190:462-469.
7. Mutter G.L., Ince T.A., Baak J.P., et al. Molecular identification of latent precancers in histologically normal endometrium. Cancer Res 2001, 61:4311-4314.
8. Mutter G.L., Lin M.C., Fitzgerald J.T., et al. Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers. J Natl Cancer Inst 2000, 92:924-930.
9. Mutter G.L., Lin M.C., Fitzgerald J.T., et al. Changes in endometrial PTEN expression throughout the human menstrual cycle. J Clin Endocrinol Metab 2000, 85:2334-2338.
10. Folkins A.K., Jarboe E.A., Saleemuddin A., et al. A candidate precursor to pelvic serous cancer (p53 signature) and its prevalence in ovaries and fallopian tubes from women with BRCA mutations. Gynecol Oncol 2008, 109:168-173.
11. Jarboe E.A., Pizer E.S., Miron A., et al. Evidence for a latent precursor (p53 signature) that may precede serous endometrial intraepithelial carcinoma. Mod Pathol 2009, 22:345-350.
12. Lacey J.V., Mutter G.L., Ronnett B.M., et al. PTEN expression in endometrial biopsies as a marker of progression to endometrial carcinoma. Cancer Res 2008, 68:6014-6020.
13. Lacey J.V., Mutter G.L., Nucci M.R., et al. Risk of subsequent endometrial carcinoma associated with endometrial intraepithelial neoplasia classification of endometrial biopsies. Cancer 2008, 113:2073-2081.
14. Mutter G.L. Histopathology of genetically defined endometrial precancers. Int J Gynecol Pathol 2000, 19:301-309.
15. Longacre T.A., Chung M.H., Jensen D.N., et al. Proposed criteria for the diagnosis of well-differentiated endometrial carcinoma. A diagnostic test for myoinvasion. Am J Surg Pathol 1995, 19:371-406.
16. Longacre T.A., Atkins K.A., Kempson R.L., et al. The uterine corpus. Diagnostic surgical pathololgy 2009, 2184-2277. Raven Press, New York. S. Sternberg, S. Mills (Eds.).
17. Hendrickson M., Kempson R. Endometrial epithelial metaplasias: proliferations frequently misdiagnosed as adenocarcinoma. Report of 89 cases and proposed classification. Am J Surg Pathol 1980, 4:525-542.
18. Young R.H., Clement P.B. Pseudoneoplastic glandular lesions of the uterine cervix. Semin Diagn Pathol 1991, 8:234-249.
19. Young R.H., Scully R.E. Atypical forms of microglandular hyperplasia of the cervix simulating carcinoma. A report of five cases and review of the literature. Am J Surg Pathol 1989, 13:50-56.
20. Young R., Scully R. Uterine carcinomas simulating microglandular hyperplasia. A report of six cases. Am J Surg Pathol 1992, 16:1092-1097.
21. Huang S., Amparo E., Fu Y. Endometrial hyperplasia: histologic classification and behavior. Surg Pathol 1988, 1:215-229.
22. Zaino R.J., Kauderer J., Trimble C.L., et al. Reproducibility of the diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006, 106:804-811.
23. Trimble C.L., Kauderer J., Zaino R., et al. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study. Cancer 2006, 106:812-819.
24. Soslow R.A. Problems with the current diagnostic approach to complex atypical endometrial hyperplasia. Cancer 2006, 106:729-731.
25. Ferenczy A., Gelfand M. The biologic significance of cytologic atypia in progestogen-treated endometrial hyperplasia. Am J Obstet Gynecol 1989, 160:126-131.
26. Ushijima K., Yahata H., Yoshikawa H., et al. Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 2007, 25:2798-2803.
27. McKenney J.K., Longacre T.A. Low-grade endometrial adenocarcinoma: a diagnostic algorithm for distinguishing atypical endometrial hyperplasia and other benign (and malignant) mimics. Adv Anat Pathol 2009, 16:1-22.
28. Nucci M.R., Prasad C.J., Crum C.P., et al. Mucinous endometrial epithelial proliferations: a morphologic spectrum of changes with diverse clinical significance. Mod Pathol 1999, 12:1137-1142.
29. Vang R., Tavassoli F.A. Proliferative mucinous lesions of the endometrium: analysis of existing criteria for diagnosing carcinoma in biopsies and curettings. Int J Surg Pathol 2003, 11:261-270.
30. Fujiwara M., Longacre T.A. Low-grade mucinous adenocarcinoma of the uterine corpus: a rare and deceptively bland form of endometrial carcinoma. Am J Surg Pathol 2011, in press.
31. Longacre T.A., Chung M.H., Rouse R.V., et al. Atypical polypoid adenomyofibromas (atypical polypoid adenomyomas) of the uterus. A clinicopathologic study of 55 cases. Am J Surg Pathol 1996, 20:1-20.
32. Mazur M. Atypical polypoid adenomyomas of the endometrium. Am J Surg Pathol 1981, 5:473-482.
33. Young R., Treger T., Scully R. Atypical polypoid adenomyoma of the uterus. A report of 27 cases. Am J Clin Pathol 1986, 86:139-145.
34. Soslow R.A., Chung M.H., Rouse R.V., et al. Atypical polypoid adenomyofibroma (APA) versus well-differentiated endometrial carcinoma with prominent stromal matrix: an immunohistochemical study. Int J Gynecol Pathol 1996, 15:209-216.
35. Gilks C.B., Young R.H., Clement P.B., et al. Adenomyomas of the uterine cervix of of endocervical type: a report of ten cases of a benign cervical tumor that may be confused with adenoma malignum [corrected]. Mod Pathol 1996, 9:220-224.
36. Silva E.G., Young R.H. Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type. Am J Surg Pathol 2007, 31:1203-1208.
37. Murray S.K., Young R.H., Scully R.E. Uterine Endometrioid Carcinoma with Small Nonvillous Papillae: An Analysis of 26 Cases of a Favorable-Prognosis Tumor To Be Distinguished from Serous Carcinoma. Int J Surg Pathol 2000, 8:279-289.
38. Clement P., Scully R. Mullerian adenosarcomas of the uterus with sex cord-like elements. A clinicopathologic analysis of eight cases. Am J Clin Pathol 1989, 91:664-672.
39. Baker R.J., Hildebrandt R.H., Rouse R.V., et al. Inhibin and CD99 (MIC2) expression in uterine stromal neoplasms with sex-cord-like elements. Hum Pathol 1999, 30:671-679.
40. Clement P., Scully R. Uterine tumors resembling ovarian sex-cord tumors. A clinicopathologic analysis of fourteen cases. Am J Clin Pathol 1976, 66:512-525.
41. Irving J.A., Carinelli S., Prat J. Uterine tumors resembling ovarian sex cord tumors are polyphenotypic neoplasms with true sex cord differentiation. Mod Pathol 2006, 19:17-24.
42. Murray S.K., Clement P.B., Young R.H. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms. Am J Surg Pathol 2005, 29:157-166.
43. Soslow R.A. Mixed müllerian tumors of the female genital tract. Surgical Pathology Clinics 2009, 2:707-730.
44. Clement P., Scully R. Mullerian adenosarcoma of the uterus: a clinicopathologic analysis of 100 cases with a review of the literature. Hum Pathol 1990, 21:363-381.
45. Kong C., Beck A., Longacre T. A panel of three markers including p16, ProEx C, or HPV ISH is optimal for distinguishing between primary endometrial and endocervical adenocarcinomas. Am J Surg Pathol 2010, 34(7):915-926.
46. Alkushi A., Irving J., Hsu F., et al. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray. Virchows Arch 2003, 442:271-277.
47. Kamoi S., AlJuboury M.I., Akin M.R., et al. Immunohistochemical staining in the distinction between primary endometrial and endocervical adenocarcinomas: another viewpoint. Int J Gynecol Pathol 2002, 21:217-223.
48. Staebler A., Sherman M.E., Zaino R.J., et al. Hormone receptor immunohistochemistry and human papillomavirus in situ hybridization are useful for distinguishing endocervical and endometrial adenocarcinomas. Am J Surg Pathol 2002, 26:998-1006.
49. McCluggage W.G., Sumathi V.P., McBride H.A., et al. A panel of immunohistochemical stains, including carcinoembryonic antigen, vimentin, and estrogen receptor, aids the distinction between primary endometrial and endocervical adenocarcinomas. Int J Gynecol Pathol 2002, 21:11-15.
50. Castrillon D.H., Lee K.R., Nucci M.R. Distinction between endometrial and endocervical adenocarcinoma: an immunohistochemical study. Int J Gynecol Pathol 2002, 21:4-10.
51. Kumar A., Schneider V. Metastases to the uterus from extrapelvic primary tumors. Int J Gynecol Pathol 1983, 2:134-140.
52. Creasman W.T., Odicino F., Maisonneuve P., et al. Carcinoma of the corpus uteri. FIGO 6th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006, 95(Suppl 1):S105-S143.
53. Wheeler D.T., Bristow R.E., Kurman R.J. Histologic alterations in endometrial hyperplasia and well-differentiated carcinoma treated with progestins. Am J Surg Pathol 2007, 31:988-998.
54. Announcements: FIGO stages - 1988 revisions. Gynecol Oncol 1989, 35:125-127.
55. Lax S.F., Kurman R.J., Pizer E.S., et al. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis. Am J Surg Pathol 2000, 24:1201-1208.
56. Alkushi A., Abdul-Rahman Z.H., Lim P., et al. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems. Am J Surg Pathol 2005, 29:295-304.
57. Taylor R.R., Zeller J., Lieberman R.W., et al. An analysis of two versus three grades for endometrial carcinoma. Gynecol Oncol 1999, 74:3-6.
58. Scholten A.N., Smit V.T., Beerman H., et al. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma. Cancer 2004, 100:764-772.
59. Gemer O., Uriev L., Voldarsky M., et al. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer. Eur J Surg Oncol 2009, 35:247-251.
60. Murray S.K., Young R.H., Scully R.E. Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance. Int J Gynecol Pathol 2003, 22:324-333.
61. Longacre T.A., Hendrickson M.R. Diffusely infiltrative endometrial adenocarcinoma: an adenoma malignum pattern of myoinvasion. Am J Surg Pathol 1999, 23:69-78.
62. Kalyanasundaram K., Ganesan R., Perunovic B., et al. Diffusely infiltrating endometrial carcinomas with no stromal response: report of a series, including cases with cervical and ovarian involvement and emphasis on the potential for misdiagnosis. Int J Surg Pathol 2010, 18(2):138-143.
63. Mittal K., Barwick K. Diffusely infiltrating adenocarcinoma of the endometrium. A subtype with poor prognosis. Am J Surg Pathol 1988, 12:754-758.
64. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. FIGO Committee on Gynecologic Oncology. Int J Gynecol Obstet 2009, 105:103-104.
65. AJCC cancer staging manual 2010, 404. Springer, New York. S.B. Edge, D.R. Byrd, C.C. Compton (Eds.).
66. Tambouret R., Clement P.B., Young R.H. Endometrial endometrioid adenocarcinoma with a deceptive pattern of spread to the uterine cervix: a manifestation of stage IIb endometrial carcinoma liable to be misinterpreted as an independent carcinoma or a benign lesion. Am J Surg Pathol 2003, 27:1080-1088.
67. McKenney J.K., Kong C.S., Longacre T.A. Endometrial adenocarcinoma associated with subtle lymph-vascular space invasion and lymph node metastasis: a histologic pattern mimicking intravascular and sinusoidal histiocytes. Int J Gynecol Pathol 2005, 24:73-78.
68. Logani S., Herdman A.V., Little J.V., et al. Vascular "pseudo invasion" in laparoscopic hysterectomy specimens: a diagnostic pitfall. Am J Surg Pathol 2008, 32:560-565.
69. Kitahara S., Walsh C., Frumovitz M., et al. Vascular pseudoinvasion in laparoscopic hysterectomy specimens for endometrial carcinoma: a grossing artifact?. Am J Surg Pathol 2009, 33:298-303.
70. Culton L.K., Deavers M.T., Silva E.G., et al. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases. Am J Surg Pathol 2006, 30:844-849.
71. Brinkmann D., Ryan A., Ayhan A., et al. A molecular genetic and statistical approach for the diagnosis of dual-site cancers. J Natl Cancer Inst 2004, 96:1441-1446.
72. Emmert-Buck M.R., Chuaqui R., Zhuang Z., et al. Molecular analysis of synchronous uterine and ovarian endometrioid tumors. Int J Gynecol Pathol 1997, 16:143-148.
73. Fujita M., Enomoto T., Wada H., et al. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer. Am J Clin Pathol 1996, 105:350-359.
74. Lin W.M., Forgacs E., Warshal D.P., et al. Loss of heterozygosity and mutational analysis of the PTEN/MMAC1 gene in synchronous endometrial and ovarian carcinomas. Clin Cancer Res 1998, 4:2577-2583.
75. Matias-Guiu X., Lagarda H., Catasus L., et al. Clonality analysis in synchronous or metachronous tumors of the female genital tract. Int J Gynecol Pathol 2002, 21:205-211.
76. Moreno-Bueno G., Gamallo C., Perez-Gallego L., et al. beta-Catenin expression pattern, beta-catenin gene mutations, and microsatellite instability in endometrioid ovarian carcinomas and synchronous endometrial carcinomas. Diagn Mol Pathol 2001, 10:116-122.
77. Shenson D.L., Gallion H.H., Powell D.E., et al. Loss of heterozygosity and genomic instability in synchronous endometrioid tumors of the ovary and endometrium. Cancer 1995, 76:650-657.
78. Ramus S.J., Elmasry K., Luo Z., et al. Predicting clinical outcome in patients diagnosed with synchronous ovarian and endometrial cancer. Clin Cancer Res 2008, 14:5840-5848.
79. Shannon C., Kirk J., Barnetson R., et al. Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin Cancer Res 2003, 9:1387-1392.